Triple negative breast cancer (TNBC) patients often acquire resistant to chemotherapy.
In the study published in Nature Communications, the authors identify the IRAK1 as the crucial driver of NF-κB-related cytokine secretion involved in TNBC metastasis and therapy resistance.
Researchers report that interleukin-1 receptor-associated kinase 1 (IRAK1) is overexpressed in a subset of breast cancers, in particular triple-negative breast cancer (TNBC), where it acts to drive aggressive growth, metastasis and acquired resistance to paclitaxel treatment.
They show that IRAK1 overexpression confers TNBC growth advantage through NF-κB-related cytokine secretion and metastatic TNBC cells exhibit gain of IRAK1 dependency, resulting in high susceptibility to genetic and pharmacologic inhibition of IRAK1.
Importantly, paclitaxel treatment induces strong IRAK1 phosphorylation, an increase in inflammatory cytokine expression, enrichment of cancer stem cells and acquired resistance to paclitaxel treatment.
Pharmacologic inhibition of IRAK1 is able to reverse paclitaxel resistance by triggering massive apoptosis at least in part through inhibiting p38-MCL1 pro-survival pathway.
The study thus demonstrates IRAK1 as a promising therapeutic target for TNBC metastasis and paclitaxel resistance.
http://www.nature.com/ncomms/2015/151027/ncomms9746/full/ncomms9746.html
Edited
Latest News
How our brain reacts to and…
By newseditor
Posted 08 Jul
Tissue-specific gene regula…
By newseditor
Posted 07 Jul
How hippocampus is activate…
By newseditor
Posted 07 Jul
Removal of excess chloride…
By newseditor
Posted 07 Jul
Intermittent fasting and br…
By newseditor
Posted 07 Jul
Other Top Stories
Side effect of keto-diet in cancer patients
Read more
Astrocyte processing of serotonin regulates olfactory perception
Read more
Biodegradable ultrasound opens the blood-brain barrier
Read more
LMAN1 is a receptor for house dust mite allergens
Read more
Role of microRNA-132 in Alzheimer's disease
Read more
Protocols
Pan-cancer proteogenomics c…
By newseditor
Posted 05 Jul
A systems biology-based ide…
By newseditor
Posted 05 Jul
Tongue orthotopic xenograft…
By newseditor
Posted 04 Jul
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Publications
Hexokinase 1 forms rings th…
By newseditor
Posted 08 Jul
Understanding gut dysbiosis…
By newseditor
Posted 08 Jul
The immune and metabolic mi…
By newseditor
Posted 08 Jul
Body Composition in Advance…
By newseditor
Posted 08 Jul
Spatiotemporal brain hierar…
By newseditor
Posted 08 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar